Ash Jogalekar
ashjogalekar.bsky.social
Ash Jogalekar
@ashjogalekar.bsky.social
I write about medicinal and computational chemistry and drug discovery with a sprinkling of history. Blog at medchemash.substack.com.
Reposted by Ash Jogalekar
Night Thoughts on the Promise of Agentic AI in Drug Discovery medchemash.substack.com/p/night-thou...
Night Thoughts on the Promise of Agentic AI in Drug Discovery
It's here, and it's real
medchemash.substack.com
October 30, 2025 at 11:44 PM
Night Thoughts on the Promise of Agentic AI in Drug Discovery medchemash.substack.com/p/night-thou...
Night Thoughts on the Promise of Agentic AI in Drug Discovery
It's here, and it's real
medchemash.substack.com
October 30, 2025 at 11:44 PM
New post: LLMs for Computational Drug Design
The continuing saga medchemash.substack.com/p/llms-for-c...
LLMs for Computational Drug Design
The continuing saga
medchemash.substack.com
October 9, 2025 at 8:51 PM
New post about a very interesting new paper: When it comes to predicting protein-ligand binding, AI don't trump physics. medchemash.substack.com/p/ai-dont-tr...
AI don't trump physics
First principles remain important
medchemash.substack.com
October 8, 2025 at 7:57 PM
New post: Frustrated PROTACs: Exceptions or the rule? Aka discomfort may be productive. medchemash.substack.com/p/frustrated...
Frustrated PROTACs: Exceptions or the rule?
Discomfort may be productive
medchemash.substack.com
October 7, 2025 at 6:15 PM
Reposted by Ash Jogalekar
From descriptive to quantitative biocatalysis

“The 1913 study ‘Die Kinetik der Invertinwirkung’, by Michaelis and Menten, marked a pivotal advancement in enzymology by illustrating the application of mechanistic models and quantitative kinetics to biocatalysis.”

doi.org/10.1038/s419...
From descriptive to quantitative biocatalysis - Nature Catalysis
The 1913 study ‘Die Kinetik der Invertinwirkung’, by Michaelis and Menten, marked a pivotal advancement in enzymology by illustrating the application of mechanistic models and quantitative kinetics to biocatalysis. The foundational framework described back then continues to have a strong impact on enzymology, with profound influences that range from undergraduate education to structure–function studies and the format and content of contemporary kinetic databases.
doi.org
September 24, 2025 at 4:13 PM
Forget “AI discovering drugs”, as I say in this post, coding for computational drug design is where the AI/LLM revolution is. medchemash.substack.com/p/code-not-d...
Code, not Drugs: The LLM Revolution in Computational Drug Design
Process before product
medchemash.substack.com
September 24, 2025 at 12:21 PM
The statistical is not the practical:
A guide to gauging the real world significance of computational methods
medchemash.substack.com/p/the-statis...
The statistical is not the practical
A guide to gauging the real world significance of computational methods
medchemash.substack.com
September 12, 2025 at 7:05 PM
Reposted by Ash Jogalekar
"Since I take solace in the belief that God looks after drunks, little children, and the USA, I still think maybe, somehow, out of chaos will come something good." —Graham Allison
September 4, 2025 at 6:10 PM
Reposted by Ash Jogalekar
Generative AI and off-the-shelf computational tools can make the synthesis and use of nerve agents for nefarious purposes more probable.

"The Sarin shortcut: How AI lowers the bar for chemical weapons," by @ashjogalekar.bsky.social. ⬇️
The Sarin shortcut: How AI lowers the bar for chemical weapons
Generative AI and off-the-shelf computational tool can make the synthesis and use of nerve agents for nefarious purposes more probable.
thebulletin.org
August 25, 2025 at 8:54 PM
1/n: Honored to publish a piece in the Bulletin of the Atomic Scientists about how AI and computational chemistry could potentially lower barriers to chemical weapons. thebulletin.org/2025/08/the-...

A summary thread about the Sarin shortcut and the dark side:
The Sarin shortcut: How AI lowers the bar for chemical weapons
Generative AI and off-the-shelf computational tool can make the synthesis and use of nerve agents for nefarious purposes more probable.
thebulletin.org
August 25, 2025 at 5:21 PM
This viewpoint is not just xenophobic but utterly stupid. Xi Jinping would like nothing more than for China’s best and brightest to stay in China. Then again, no act of self-sabotage could be big enough for this anti-American administration. www.wsj.com/opinion/send...
Opinion | Send Harvard’s Chinese Students Home
It makes no sense for the U.S. to be educating the scientific and leadership class of a future adversary.
www.wsj.com
August 20, 2025 at 3:48 PM
Reposted by Ash Jogalekar
Drawing on the wisdom of Forrest Gump and Dave Allen, I’ve reviewed Churcher, Newbold & Murray (2025) Return to Flatland, Nat Rev Chem 9:140–141 DOI: 10.1038/s41570-025-00688-5 #Fsp3 #DrugDesign #DrugDiscovery #metric #cheminformatics #MedChem #chemsky 🧪
fbdd-lit.blogspot.com/2025/08/retu...
fbdd-lit.blogspot.com
August 6, 2025 at 9:43 AM
That's usually a good sign that you need to switch to an alternative protocol.
July 23, 2025 at 5:54 PM
In today's version of "How selective might this compound be?"
July 22, 2025 at 10:14 PM
Reposted by Ash Jogalekar
Highlights for those without a subscription:
1: California launched the biotech revolution with Genentech in 1976. Today, it's home to 16,500+ life sciences firms and generates $414B in economic output. But federal disinvestment threatens to stall our lead.
July 21, 2025 at 9:22 PM
Reposted by Ash Jogalekar
Today's #RDKit blog post is a heartfelt plea for clearer communication.
greglandrum.github.io/rdkit-blog/p...
Please stop saying “The Tanimoto similarity is” – RDKit blog
A simple tip to explain what you actually did
greglandrum.github.io
July 17, 2025 at 11:22 AM
Reposted by Ash Jogalekar
My Op-Ed on the U.S-China biotech race is out today in the San Francisco Chronicle. The data speaks for itself, and we need to get our act together to maintain our lead in biotech innovation. www.sfchronicle.com/opinion/open...
The U.S. is losing its biotech edge over China — and that’s bad news for the Bay Area
OPINION: From gene therapies to cancer breakthroughs, California has been the driving force behind America’s biotechnology industry. But today, that edge is slipping.
www.sfchronicle.com
July 21, 2025 at 1:38 PM
Another day, another report on generic electron-rich aromatics seemingly inhibiting target X with specificity and potency without any tests on non-specific inhibition.
July 10, 2025 at 9:28 PM
I'm glad chatGPT can now use RDKit, but as my query to draw vemurafenib and illustrate its tautomers shows, there's work to be done, especially since that's not vemurafenib and those are not its tautomers.
July 3, 2025 at 11:30 PM